Compound heterozygous mutations in UBA5 causing early-onset epileptic encephalopathy in two sisters.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Arnadottir, Gudny AJensson, Brynjar O
Marelsson, Sigurdur E
Sulem, Gerald
Oddsson, Asmundur
Kristjansson, Ragnar P
Benonisdottir, Stefania
Gudjonsson, Sigurjon A
Masson, Gisli
Thorisson, Gudmundur A
Saemundsdottir, Jona
Magnusson, Olafur Th
Jonasdottir, Adalbjorg
Jonasdottir, Aslaug
Sigurdsson, Asgeir
Gudbjartsson, Daniel F
Thorsteinsdottir, Unnur
Arngrimsson, Reynir
Sulem, Patrick
Stefansson, Kari
Issue Date
2017-10-02
Metadata
Show full item recordCitation
Compound heterozygous mutations in UBA5 causing early-onset epileptic encephalopathy in two sisters. 2017, 18 (1):103 BMC Med. Genet.Abstract
Epileptic encephalopathies are a group of childhood epilepsies that display high phenotypic and genetic heterogeneity. The recent, extensive use of next-generation sequencing has identified a large number of genes in epileptic encephalopathies, including UBA5 in which biallelic mutations were first described as pathogenic in 2016 (Colin E et al., Am J Hum Genet 99(3):695-703, 2016. Muona M et al., Am J Hum Genet 99(3):683-694, 2016). UBA5 encodes an activating enzyme for a post-translational modification mechanism known as ufmylation, and is the first gene from the ufmylation pathway that is linked to disease.We sequenced the genomes of two sisters with early-onset epileptic encephalopathy along with their unaffected parents in an attempt to find a genetic cause for their condition. The sisters, born in 2004 and 2006, presented with infantile spasms at six months of age, which later progressed to recurrent, treatment-resistant seizures. We detected a compound heterozygous genotype in UBA5 in the sisters, a genotype not seen elsewhere in an Icelandic reference set of 30,067 individuals nor in public databases. One of the mutations, c.684G > A, is a paternally inherited exonic splicing mutation, occuring at the last nucleotide of exon 7 of UBA5. The mutation is predicted to disrupt the splice site, resulting in loss-of-function of one allele of UBA5. The second mutation is a maternally inherited missense mutation, p.Ala371Thr, previously reported as pathogenic when in compound heterozygosity with a loss-of-function mutation in UBA5 and is believed to produce a hypomorphic allele. Supportive of this, we have identified three adult Icelanders homozygous for the p.Ala371Thr mutation who show no signs of neurological disease.
We describe compound heterozygous mutations in the UBA5 gene in two sisters with early-onset epileptic encephalopathy. To our knowledge, this is the first description of mutations in UBA5 since the initial discovery that pathogenic biallelic variants in the gene cause early-onset epileptic encephalopathy. We further provide confirmatory evidence that p.Ala371Thr is a hypomorphic mutation, by presenting three adult homozygotes who show no signs of neurological disease.
Description
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked FilesAdditional Links
https://bmcmedgenet.biomedcentral.com/track/pdf/10.1186/s12881-017-0466-8?site=bmcmedgenet.biomedcentral.comRights
Archived with thanks to BMC medical geneticsae974a485f413a2113503eed53cd6c53
10.1186/s12881-017-0466-8
Scopus Count
Collections
Related articles
- Biallelic Variants in UBA5 Link Dysfunctional UFM1 Ubiquitin-like Modifier Pathway to Severe Infantile-Onset Encephalopathy.
- Authors: Muona M, Ishimura R, Laari A, Ichimura Y, Linnankivi T, Keski-Filppula R, Herva R, Rantala H, Paetau A, Pöyhönen M, Obata M, Uemura T, Karhu T, Bizen N, Takebayashi H, McKee S, Parker MJ, Akawi N, McRae J, Hurles ME, DDD Study., Kuismin O, Kurki MI, Anttonen AK, Tanaka K, Palotie A, Waguri S, Lehesjoki AE, Komatsu M
- Issue date: 2016 Sep 1
- Biallelic loss-of-function UBA5 mutations in a patient with intractable West syndrome and profound failure to thrive.
- Authors: Daida A, Hamano SI, Ikemoto S, Matsuura R, Nakashima M, Matsumoto N, Kato M
- Issue date: 2018 Aug 1
- Abnormal function of the UBA5 protein in a case of early developmental and epileptic encephalopathy with suppression-burst.
- Authors: Mignon-Ravix C, Milh M, Kaiser CS, Daniel J, Riccardi F, Cacciagli P, Nagara M, Busa T, Liebau E, Villard L
- Issue date: 2018 Jul
- SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures.
- Authors: Wang J, Gao H, Bao X, Zhang Q, Li J, Wei L, Wu X, Chen Y, Yu S
- Issue date: 2017 Sep 18
- Biallelic Variants in UBA5 Reveal that Disruption of the UFM1 Cascade Can Result in Early-Onset Encephalopathy.
- Authors: Colin E, Daniel J, Ziegler A, Wakim J, Scrivo A, Haack TB, Khiati S, Denommé AS, Amati-Bonneau P, Charif M, Procaccio V, Reynier P, Aleck KA, Botto LD, Herper CL, Kaiser CS, Nabbout R, N'Guyen S, Mora-Lorca JA, Assmann B, Christ S, Meitinger T, Strom TM, Prokisch H, FREX Consortium., Miranda-Vizuete A, Hoffmann GF, Lenaers G, Bomont P, Liebau E, Bonneau D
- Issue date: 2016 Sep 1